Dr. Bastian Dehmel Appointed CMO of OxThera

STOCKHOLM, October 13, 2017 /PRNewswire/ —
OxThera AB, a Stockholm-based privately-held biopharmaceutical company today announced the appointment of Dr. Bastian Dehmel as their new Chief Medical Officer.  
OxThera is developing a novel treatment, Oxab…
Source: PRNewsWire-USA

Dr. Bastian Dehmel Appointed CMO of OxThera